Tatva Chintan Pharma Chem Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Tatva Chintan Pharma Chem Share Price

1,143.2029.50 (2.65%)

Live
As On: 11 Jun, 2026, 02:53 PM IST
As On: 11 Jun, 2026, 02:53 PM IST

Sector: Chemicals
Industry: Chemicals - Others

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	1,122.50
High	1,157.80
Low	1,111.50
Prev Close	1,113.70
Volume	24,445
VWAP(₹)	1,133.19

Key Metrics

PE Ratio(x)	63.26
EPS - TTM(₹)	17.98
MCap(₹ Cr.)	2,660.38
MCap Rank	40
PB Ratio(x)	3.33
Div Yield(%)	0.18
Face Value(₹)	10.00
52W High(₹)	1,610.00
52W Low(₹)	886.00
MCap/Sales	4.86
Beta(1 Month)	-
BV/Share(₹)	334.20

Tatva Chintan Pharma Chem share price insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 32.3% outperformed its 3 year CAGR of 5.8%. (Source: Consolidated Financials)
Increase in Cash from Investing
Company has used Rs 115.84 cr for investing activities which is an YoY increase of 77.52%. (Source: Consolidated Financials)
Tatva Chintan Pharma Chem Share Price Update
Tatva Chintan Pharma Chem Ltd. share price moved up by 2.65% from its previous close of Rs 1,113.70. Tatva Chintan Pharma Chem Ltd. stock last traded price is 1,143.20
Share Price Value
Today/Current/Last 1,143.201,147.95
Previous Day 1,113.701,113.25

Found Insights useful?

Tatva Chintan Pharma Chem Share Price Returns

1 Day	2.65%
1 Month	-14.28%
3 Months	-0.59%
1 Year	19.86%
3 Years	-34.02%
5 Years	N.A.

Tatva Chintan Pharma Chem Share Recommendations

Mean recosCurrent

HOLD

3 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	1	1	1	1
Buy	-	-	-	-
Hold	-	-	-	1
Sell	1	1	1	1
Strong Sell	1	1	1	1
# Analysts	3	3	3	4

Recent Recos

Target₹1590
OrganizationPrabhudas Lilladher
BUY

Target₹2000
OrganizationICICI Securities
BUY

Target₹2730
OrganizationICICI Securities
BUY

View all Stock Recommendations

News & Analysis

View all Tatva Chintan Pharma Chem Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	133.80	133.07	124.52	118.02	108.59
Total Income Growth (%)	0.55	6.86	5.51	8.69	26.35
Total Expenses	115.77	114.92	110.35	108.51	106.17
Total Expenses Growth (%)	0.74	4.13	1.70	2.20	23.80
EBIT	18.03	18.15	14.17	9.51	2.42
EBIT Growth (%)	-0.69	28.09	48.94	293.95	1,234.25
Profit after Tax (PAT)	10.32	15.17	9.92	6.65	1.03
PAT Growth (%)	-31.94	52.92	49.11	545.73	646.38
EBIT Margin (%)	13.47	13.64	11.38	8.06	2.22
Net Profit Margin (%)	7.71	11.40	7.96	5.64	0.95
Basic EPS (₹)	4.41	6.49	4.24	2.84	0.44

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	132.30	140.32	116.66	110.55	108.94
Total Income Growth (%)	-5.72	20.29	5.53	1.47	29.63
Total Expenses	115.88	121.04	103.81	103.08	107.00
Total Expenses Growth (%)	-4.26	16.60	0.70	-3.66	25.48
EBIT	16.41	19.29	12.85	7.47	1.94
EBIT Growth (%)	-14.89	50.08	72.09	284.50	-
Profit after Tax (PAT)	9.02	15.98	8.94	5.13	1.10
PAT Growth (%)	-43.55	78.77	74.19	368.77	-
EBIT Margin (%)	12.41	13.74	11.02	6.75	1.78
Net Profit Margin (%)	6.82	11.39	7.66	4.64	1.01
Basic EPS (₹)	3.86	6.84	3.82	2.19	0.47

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	509.41	385.03	401.01	429.36	442.54
Total Revenue Growth (%)	32.30	-3.99	-6.60	-2.98	44.48
Total Expenses	452.40	377.45	357.45	380.99	338.42
Total Expenses Growth (%)	19.86	5.60	-6.18	12.58	37.80
Profit after Tax (PAT)	42.05	5.71	30.35	45.49	95.87
PAT Growth (%)	636.11	-81.18	-33.27	-52.56	83.45
Operating Profit Margin (%)	11.83	2.31	12.73	13.40	25.12
Net Profit Margin (%)	8.31	1.49	7.71	10.73	22.10
Basic EPS (₹)	17.98	2.44	13.26	20.52	44.59

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	499.82	369.98	386.19	408.72	438.32
Total Revenue Growth (%)	35.10	-4.20	-5.51	-6.75	47.94
Total Expenses	446.66	369.52	343.92	366.30	335.05
Total Expenses Growth (%)	20.88	7.44	-6.11	9.33	41.41
Profit after Tax (PAT)	39.08	0.33	29.35	40.47	95.99
PAT Growth (%)	0.00	-98.89	-27.47	-57.84	86.89
Operating Profit Margin (%)	11.28	0.47	12.87	12.60	25.26
Net Profit Margin (%)	7.87	0.08	7.75	10.03	22.43
Basic EPS (₹)	16.71	0.14	12.82	18.26	44.65

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 32.3% outperformed its 3 year CAGR of 5.8%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	1,003.69	836.25	818.72	756.30	658.30
Total Assets Growth (%)	20.02	2.14	8.25	14.89	109.12
Total Liabilities	221.94	97.43	81.64	241.51	185.21
Total Liabilities Growth (%)	127.80	19.34	-66.20	30.40	24.44
Total Equity	781.76	738.82	737.08	514.79	473.09
Total Equity Growth (%)	5.81	0.24	43.18	8.81	185.06
Current Ratio (x)	1.64	2.76	3.74	1.33	2.54
Total Debt to Equity (x)	0.15	0.05	0.02	0.33	0.25
Contingent Liabilities	0.00	17.17	34.66	19.19	80.05

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	995.38	822.80	815.07	754.86	652.25
Total Assets Growth (%)	20.97	0.95	7.98	15.73	110.62
Total Liabilities	237.15	101.49	89.19	250.08	183.37
Total Liabilities Growth (%)	133.67	13.79	-64.34	36.38	24.11
Total Equity	758.23	721.31	725.88	504.78	468.88
Total Equity Growth (%)	5.12	-0.63	43.80	7.66	189.54
Current Ratio (x)	1.50	2.51	3.37	1.27	2.53
Total Debt to Equity (x)	0.16	0.05	0.02	0.34	0.26
Contingent Liabilities	0.00	17.17	29.96	19.19	79.05

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	31.49	24.67	98.04	27.78	20.38
Net Cash used in Investing Activities	-115.84	-65.25	-120.54	-101.14	-196.81
Net Cash flow from Financing Activities	78.93	16.57	30.52	37.80	234.96
Net Cash Flow	-5.61	-23.93	7.94	-35.65	58.54
Closing Cash & Cash Equivalent	5.76	11.37	35.30	27.37	63.02
Closing Cash & Cash Equivalent Growth (%)	-49.32	-67.78	29.01	-56.57	1,079.87
Total Debt/ CFO (x)	3.82	1.47	0.15	6.13	5.89

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	29.17	23.91	102.78	23.73	19.89
Net Cash used in Investing Activities	-115.83	-65.25	-120.54	-101.12	-196.81
Net Cash flow from Financing Activities	78.93	16.57	30.54	37.82	234.96
Net Cash Flow	-7.74	-24.78	12.80	-39.59	58.05
Closing Cash & Cash Equivalent	1.47	9.21	33.99	21.19	60.78
Closing Cash & Cash Equivalent Growth (%)	-84.03	-72.92	60.41	-65.14	1,594.31
Total Debt/ CFO (x)	4.13	1.52	0.14	7.18	6.03

All figures in Rs Cr, unless mentioned otherwise

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 31.49 cr is 0.75 times compared to the reported net profit of Rs 42.05 cr. (Source: Consolidated Financials)
Increase in Cash from Investing
Company has used Rs 115.84 cr for investing activities which is an YoY increase of 77.52%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	5.37	0.77	4.11	8.83	20.26
Return on Capital Employed (%)	7.57	1.19	6.77	10.91	22.37
Return on Assets (%)	4.18	0.68	3.70	6.01	14.56
Interest Coverage Ratio (x)	33.92	28.32	11.59	7.89	24.24
Asset Turnover Ratio (x)	0.55	0.46	0.50	0.60	0.88
Price to Earnings (x)	58.48	285.71	83.33	81.30	53.48
Price to Book (x)	3.14	2.15	3.43	7.18	10.81
EV/EBITDA (x)	26.57	44.09	33.04	57.60	43.18
EBITDA Margin (%)	19.11	9.54	19.23	15.65	27.01

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	5.15	0.04	4.04	8.01	20.47
Return on Capital Employed (%)	7.30	0.24	6.70	9.95	22.39
Return on Assets (%)	3.92	0.03	3.60	5.36	14.71
Interest Coverage Ratio (x)	32.57	22.79	11.43	7.20	24.06
Asset Turnover Ratio (x)	0.55	0.45	0.48	0.57	0.89
Price to Earnings (x)	63.29	5,000.00	86.21	91.74	53.48
Price to Book (x)	3.24	2.20	3.48	7.32	10.91
EV/EBITDA (x)	27.72	54.84	33.65	63.40	43.52
EBITDA Margin (%)	18.71	8.02	19.64	14.97	27.17

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Tatva Chintan Pharma Chem	63.97	3.44	5.37	7.57	4.18	5.80	11.83	8.31	17.98	1.64	0.15	3.82
Fineotex Chem	40.35	4.67	12.32	16.18	9.38	15.21	19.99	16.18	1.09	2.80	0.01	-0.34
Yasho Industries	122.11	6.95	5.68	11.33	2.18	6.72	10.80	3.04	20.95	1.37	1.22	3.58
Thirumalai Chem	-11.78	1.27	-10.73	-3.04	-3.54	-6.67	-6.03	-9.67	-14.91	0.61	1.34	-16.01
S H Kelkar & Co.	24.58	1.25	5.08	7.52	2.37	11.75	5.57	2.91	5.00	1.27	0.62	3.23
Add More

Annual Ratios (%)

Choose from Peers

Gulshan Polyols
Meghmani Organics
Shree Pushkar Chem
Chemcon Speciality
Jayant Agro Org

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 1,68,47,063 72.02 % 0.00
Pledge 0 0.00 % 0.00
FII 8,92,920 3.81 % -0.35
DII 6,98,939 2.99 % -0.32
MF 6,71,739 2.87 % -0.37
Others 49,53,133 21.18 % 0.68
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 72.02 72.02 72.02 72.02
Pledge 0.00 0.00 0.00 0.00
FII 3.81 4.17 3.40 3.26
DII 2.99 3.32 3.86 5.11
Mutual Funds 2.87 3.25 3.82 5.07
Others 21.18 20.49 20.72 19.61

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Nippon India ELSS Tax Saver Direct-G
Equity: ELSS
4
- 67.74
  Amount Invested (in Cr.)
- 0.46%
  % of AUM
- -3.73
  % Change (MoM basis)
ICICI Pru MNC Direct-G
Equity: Thematic-MNC
- 8.80
  Amount Invested (in Cr.)
- 0.51291922%
  % of AUM
- 0.00
  % Change (MoM basis)
ICICI Pru Commodities Direct-G
Equity: Thematic
- 7.44
  Amount Invested (in Cr.)
- 0.19634675%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Tatva Chintan Pharma Chem Top Searches

Corporate Actions

Recent
Board Meeting
Quarterly Results
Jan 12, 2026
Board Meeting
Quarterly Results
Oct 17, 2025
General Meeting
-
Aug 26, 2025

Announced on	Meeting on
Jan 12, 2026	Jan 21, 2026
Quarterly Results
Oct 17, 2025	Oct 31, 2025
Quarterly Results
Jul 17, 2025	Jul 24, 2025
Quarterly Results
Apr 25, 2025	May 02, 2025
Audited Results & Final Dividend
Jan 17, 2025	Jan 28, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 02, 2025 Sep 12, 2025 10%
May 03, 2024 Sep 06, 2024 20%
May 05, 2023 Sep 08, 2023 20%
Apr 25, 2022 Sep 08, 2022 20%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

AGM/EGM Meetings

Announced on	Meeting on
Aug 26, 2025	Sep 26, 2025
-
Aug 27, 2024	Sep 20, 2024
Rs.2.0000 per share(20%)Final Dividend & A.G.M.
Aug 28, 2023	Sep 22, 2023
Rs.2.0000 per share(20%)Final Dividend & A.G.M.
Jul 14, 2023	Aug 15, 2023
-

About Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 2,605.17 Crore) operating in Chemicals sector.

Tatva Chintan Pharma Chem Ltd. key Products/Revenue Segments include Speciality Chemicals, Scrap and Export Incentives for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 133.80 Crore, up .55 % from last quarter Total Income of Rs 133.07 Crore and up 23.22 % from last year same quarter Total Income of Rs 108.59 Crore. Company has reported net profit after tax of Rs 10.32 Crore in latest quarter.

The company’s top management includes Mr.Chintan Nitinkumar Shah, Mr.Ajaykumar Mansukhlal Patel, Mr.Shekhar Rasiklal Somani, Dr.Avani Rajesh Umatt, Dr.Manher Chimanlal Desai, Mr.Subhash Ambubhai Patel, Mr.Ashok Bothra, Mr.Ishwar Nayi. Company has NDJ & Co. as its auditors. As on 31-03-2026, the company has a total of 2.34 Crore shares outstanding.

Tatva Chintan Pharma Chem Share Price Today is Rs. 1143.20. On previous day, the Tatva Chintan Pharma Chem Share Price (NSE) closed at Rs. 1160.0, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 72.02% of the stake in Tatva Chintan Pharma Chem shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Tatva Chintan Pharma Chem stocks was 3.81% as compared to 4.17% in Dec 2025 with decrease of 0.36%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 2.99% as compared to 3.32% in Dec 2025 with decrease of 0.33%. Out of the total DII holdings in Tatva Chintan Pharma Chem shares 2.87% was held by mutual funds. The rest including public held is 21.18%. Tatva Chintan Pharma Chem stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Tatva Chintan Pharma Chem Dividend: Ever since 1996, Tatva Chintan Pharma Chem dividends has been paid out around 5 times. As on 11 Jun, 2026, 02:53 PM IST, The overall dividend yield for Tatva Chintan Pharma Chem stands at 0.18%. The last dividend paid was on September 12, 2025 (Rs. 1.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 17.98.

Tatva Chintan Pharma Chem Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 133.8 Cr. of sales and 0.55% of quarterly net profit, there have been multiple ups and downs in the Tatva Chintan Pharma Chem stock prices in the past few weeks. For example, Tatva Chintan Pharma Chem stock price on 3rd of June 2026 was around Rs. 1222.4. Tatva Chintan Pharma Chem share price now stands at an average of Rs. 1143.20. Judging by last week's performance, stock is in down trend.

Tatva Chintan Pharma Chem has a median target price of Rs. 1390.0 in 12 months by 3 analysts. They have provided a high estimate of Rs. 1955.0 and low estimate of Rs. 835.0 for Tatva Chintan Pharma Chem share.

Historical Prices and Performance:
Tatva Chintan Pharma Chem, incorporated in 1996 is a Small Cap company (with a market cap of Rs. 2605.17) operating in Chemicals sector.
The Return of Equity (ROE) in last five financial years given by Tatva Chintan Pharma Chem stock was 5.37%, 0.77%, 4.11%, 8.83% and 20.26% respectively.
The Tatva Chintan Pharma Chem share gave a 3 year return of -35.72% as compared to Nifty 50 which gave a return of 25.06%.
Tatva Chintan Pharma Chem announced 10.0% final dividend on September 12, 2025.

Key Metrics:
PE Ratio of Tatva Chintan Pharma Chem is 61.95
Prices/Sales Ratio of Tatva Chintan Pharma Chem is 4.86
Price/Book Ratio of Tatva Chintan Pharma Chem is 3.33

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Tatva Chintan Pharma Chem, major competitors and peers include Fineotex Chem, Yasho Industries, Thirumalai Chem and S H Kelkar & Co.. As of Dec 2025, the dividend yield of Tatva Chintan Pharma Chem stands at 0.18% while Fineotex Chem, Yasho Industries, Thirumalai Chem and S H Kelkar & Co. stand at 1.18%, 0.02%, 0.0% and 0.82% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 61.95 and 3.33 respectively.

Leadership of Tatva Chintan Pharma Chem :
Ishwar Nayi is Co. Secretary & Compl. Officer
Ashok Bothra is Chief Financial Officer
Chintan Nitinkumar Shah is Chairman & Managing Director
Ajaykumar Mansukhlal Patel is Whole Time Director
Shekhar Rasiklal Somani is Whole Time Director
Manher Chimanlal Desai is Independent Director
Subhash Ambubhai Patel is Independent Director
Avani Rajesh Umatt is Independent Director

Show More

Industry

Chemicals - Others

Key Indices Listed On

BSE SmallCap, BSE Commodities, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500

Address

Plot No. 502/17,GIDC Estate,Ankleshwar,Bharuch District, Gujarat - 390002

Contact

cs@tatvachintan.com

http://www.tatvachintan.com

Executive Leadership

CN

Chintan Nitinkumar Shah

Chairman & Managing Director

AM

Ajaykumar Mansukhlal Patel

Whole Time Director

SR

Shekhar Rasiklal Somani

Whole Time Director

AR

Avani Rajesh Umatt

Independent Director

Show More

Auditors

NDJ & Co.

FAQs about Tatva Chintan Pharma Chem share

1. What's the Tatva Chintan Pharma Chem share price today?
Tatva Chintan Pharma Chem share price is Rs 1,143.20 as on 11 Jun, 2026, 02:53 PM IST. Tatva Chintan Pharma Chem share price is up by 2.65% based on previous share price of Rs 1,160. Tatva Chintan Pharma Chem share price trend:
- Last 12 Months: Tatva Chintan Pharma Chem share price moved up 19.86%
- Last 3 Years: Tatva Chintan Pharma Chem Share price moved down by 34.02%
2. What is the market cap of Tatva Chintan Pharma Chem?
Market Capitalization of Tatva Chintan Pharma Chem stock is Rs 2,660.38 Cr.
3. What is the PE & PB ratio of Tatva Chintan Pharma Chem?
The PE ratio of Tatva Chintan Pharma Chem stands at 61.95, while the PB ratio is 3.33.
4. What are the returns for Tatva Chintan Pharma Chem share?
Return Performance of Tatva Chintan Pharma Chem Shares:
- 1 Week: Tatva Chintan Pharma Chem share price moved down by 4.02%
5. What has been highest price of Tatva Chintan Pharma Chem share in last 52 weeks?
52 Week high of Tatva Chintan Pharma Chem share is Rs 1,610.00 while 52 week low is Rs 886.00

Top Gainers

As on 02:49 PM | 11 Jun 2026

Aegis Logistics

899.90

98.90 (12.35%)

110.67

7.74 (7.52%)

Blue Jet Healthcare

504.40

34.65 (7.38%)

DOMS Industries

2,244.80

126.21 (5.96%)

1,924.60

91.60 (5.00%)

Top Losers

As on 02:49 PM | 11 Jun 2026

160.66

-8.46 (-5.00%)

155.59

-8.04 (-4.91%)

Ola Electric Mobilit

45.02

-2.30 (-4.87%)

1,015.30

-51.00 (-4.79%)

Balkrishna Ind.

1,986.70

-96.50 (-4.64%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.